DOST to start June study on mixing COVID-19 vaccine brands
The Department of Science and Technology (DOST) plans to start a local study on mixing different COVID-19 vaccine brands in June.
The 18-month study, which aims to assess safety and immunogenicity, will focus primarily on combining Sinovac with other vaccines due to its stable supply.
The PHP133 million-funded project seeks to address concerns related to unpredictable vaccine supplies and determine if high-risk populations show better immune responses after booster doses.
DOST Secretary Fortunato de la Peña stated that the study, led by Dr. Michelle De Vera of the Philippine Society for Allergy, Asthma, and Immunology, will involve 1,200 participants across eight proposed sites nationwide.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.